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Computational modeling of functional brain networks in fMRI data has advanced the under-
standing of higher cognitive function. It is hypothesized that functional networks mediating
higher cognitive processes are disrupted in people with schizophrenia. In this article, we
review studies that applied measures of functional and effective connectivity to fMRI data
during cognitive tasks, in particular working memory fMRI studies.We provide a conceptual
summary of the main findings in fMRI data and their relationship with neurotransmitter
systems, which are known to be altered in individuals with schizophrenia. We consider
possible developments in computational neuropsychiatry, which are likely to further our
understanding of how key functional networks are altered in schizophrenia.
Keywords: computational neuropsychiatry, schizophrenia, fMRI, dynamic causal modeling, cognition,
neurotransmitter, dopamine, glutamate
INTRODUCTION
Schizophrenia is a severe psychiatric disorder, which is initially
manifested through positive symptoms including delusions, hal-
lucinations, and disorganized thoughts. As the illness progresses
negative symptoms such as avolition, alogia, and apathy may occur.
Prior to diagnosis of illness, cognitive deficits can occur and illness
progression can also be associated with cognitive deficits (1, 2). It
is widely established that such cognitive deficits are considered a
core symptom of schizophrenia (3) and are associated with reduc-
tions in working memory performance. Working memory deficits
are one of the main neurocognitive impairments found in subjects
Abbreviations: AC/ACC, anterior cingulate/anterior cingulate cortex; ARMS, at-
risk mental state; BMS, Bayesian model selection; BOLD response, blood-oxygen-
level dependent response; D1 receptor, D1 subtype of the dopamine receptor; D2
receptor, D2 subtype of the dopamine receptor; D2/3 receptors, D2/3 subtype of
the dopamine receptor; DCM, Dynamic Causal Modeling; DMN, default-mode
network; DLPFC, dorsolateral prefrontal cortex; EC, effective connectivity; EST, sub-
jects with EST; FC, functional connectivity; FEP, subjects with first episode psychosis;
FES, subjects with first episode schizophrenia; GABA, γ-aminobutyric acid; GBC,
global-based connectivity; HR, subjects at high risk of schizophrenia; HR+, subjects
at high familial risk of schizophrenia with transient psychotic symptoms; HR−, sub-
jects at high familial risk of schizophrenia without transient psychotic symptoms;
HRill, subjects at high familial risk of schizophrenia who subsequent to scanning
developed schizophrenia; HSCT, Hayling sentence completion task IFG inferior
frontal gyrus; MFG, middle frontal gyrus; MRS, magnetic resonance spectroscopy;
NMDA, N -Methyl-d-aspartate acid; PC, parietal cortex; PET, positron emission
tomography; rCBF, regional cerebral blood flow; SPECT, single-photon emission
computed tomography; SPL, superior parietal lobe; STG, superior temporal gyrus.
with first episode schizophrenia (FES) (4, 5) and in people with
established schizophrenia (EST) (6). Similar deficits also occur
in individuals at high risk of schizophrenia [HR; Ref. (2)]. Fur-
thermore, recent evidence has been presented, which indicates a
relationship between severity of working memory deficits and the
severity of negative symptoms (7). The severity of working mem-
ory deficits that is evident at the first episode of schizophrenia can
predict the quality of life at the established stage of the illness (8, 9).
Two major neurotransmitter circuits have been implicated in
clinical and cognitive symptoms in subjects with schizophrenia:
these are the dopamine and glutamate neurotransmitter circuits.
Evidence has been presented for separate alterations/disruptions of
dopamine and glutamate as well as an interactive role between both
neurotransmitters1. The two main neurobiological hypotheses
in schizophrenia are based on the theories of altered dopamin-
ergic transmission (“dopamine hypothesis of schizophrenia”)
and altered glutamatergic transmission (“glutamate hypothesis
of schizophrenia”). It is thought that both dopamine and glu-
tamate modulate the dorsolateral prefrontal cortex (DLPFC) and
in schizophrenia alter the performance in cognitive processes such
as in working memory (10–13). Such work supports the notion
of schizophrenia as a brain disorder. FMRI and positron emission
tomography (PET) findings of altered functional activation and
functional connectivity (FC) during working memory have been
1It is noted that other neurotransmitter circuits are interacting with dopaminergic
and/or glutamatergic circuits such as serotonin and GABA (24, 29, 149).
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reported in people with schizophrenia when they are compared to
healthy controls (14, 15). Furthermore, PET studies have presented
evidence for indirect markers of altered dopamine transmission,
which was correlated with working memory performance (2, 16).
Alterations of indirect measures of glutamate concentrations have
been reported by proton magnetic resonance spectroscopy (MRS)
studies (17).
One subfield within the emerging field of computational neu-
ropsychiatry is based on modeling fMRI networks and the evi-
dence of (i) altered dopaminergic and/or glutamatergic transmis-
sion in (ii) cognitive function (i.e., working memory) in people
with schizophrenia. Therefore, the objectives are the investigation
of impaired cognitive function mediated by large-scale networks
in combination with underlying neurobiological circuits such as
dopamine and glutamate. Researchers in computational neuropsy-
chiatry examine and model altered cognitive brain function in
terms of functionally integrated regions [i.e., effective connectiv-
ity (EC)] (18), which may be mediated by genetic factors and
neurotransmitter circuits (19–21). Mechanistic responses can be
inferred from the computational modeling of cognitive brain func-
tion where the localized brain function is monitored through
the BOLD response (22). This modeling approach allows com-
putational neuropsychiatry to further our understanding of the
neurobiological processes, which underlie altered cognitive brain
function in individuals with schizophrenia. Thus, advancing our
knowledge of schizophrenia as a cognitive brain network disorder.
In this review, we summarize fMRI findings in verbal/numeric
working memory2 in context of (i) the understanding of schizo-
phrenia as a cognitive brain disorder (from clinical and cognitive
neurosciences) and (ii) the understanding of schizophrenia as
a cognitive brain network disorder (from computational neu-
ropsychiatry). We discuss these sets of findings in context of the
dopamine and the glutamate hypotheses of schizophrenia. We
consider two key research questions for the discussion of each
set of findings:
(i) To what extent do these sets of findings support the dopamine
hypothesis and/or the glutamate hypothesis in subjects with
schizophrenia?
(ii) Do the findings from computational neuropsychiatry lead to
a better understanding of schizophrenia than that obtained
from clinical and cognitive neurosciences?
The review is structured as followed: first, the dopamine and
glutamate hypotheses of schizophrenia are summarized (Section
Schizophrenia as a Brain Disorder). Second, exemplary findings
of verbal/numeric working memory deficits from fMRI studies
in subjects with schizophrenia are summarized. These findings
are discussed in context of the dopamine hypothesis and the glu-
tamate hypothesis of schizophrenia (Section Schizophrenia as a
Cognitive Brain Disorder). Third, we present a brief introduc-
tion to computational neuropsychiatry. We provide examples from
2In this review, we focus on the “2-back” task [verbal “2-back”, (104); numeric
“2-back”, (97)] to review/discuss brain function and PET findings of compara-
ble experimental paradigms, psychological/ cognitive domains/components and
activated brain regions.
computational neuropsychiatry and the application to the investi-
gation of cognitive brain large-scale networks in people with schiz-
ophrenia3. Finally, we consider current methodological limitations
of the methods (Section From Computational Neuropsychiatry
Towards Schizophrenia as a Cognitive Brain Network Disorder).
We outline potential future influences of computational advances
in schizophrenia that may shape our understanding of schizophre-
nia with the aim of developing more effective treatments for the
disorder (Section Understanding of Schizophrenia).
SCHIZOPHRENIA AS A BRAIN DISORDER
Neurobiological research into alterations of dopaminergic and/or
glutamatergic neurotransmission has paved the way for the under-
standing of schizophrenia as a disorder of the brain. The dopamine
hypothesis posits that dopamine function is altered in schizo-
phrenia and that this dysfunction may be the pathophysiological
pathway leading to clinical and cognitive symptoms (23, 24).
The glutamate hypothesis proposes that the altered dopaminergic
dysfunction may be secondary to aberrant glutamatergic dysreg-
ulation, which may contribute to clinical and cognitive symptoms
in schizophrenia (25–27).
DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA
The origin of the dopamine hypothesis of schizophrenia is based
on the discovery of antipsychotic drugs by Delay et al. (28) in
1952. Carlsson and Lindqvit reported the first findings of an
effect of antipsychotic drugs on the metabolism of dopamine (29).
The dopamine hypothesis posits that alterations of dopaminergic
receptors may underlie the clinical symptoms of schizophrenia
(30). Over last three decades, the dopamine hypothesis of schiz-
ophrenia has undergone reformulations in light of newly avail-
able preclinical and clinical findings. Here, we consider the three
main hypotheses: (i) the “dopamine receptor hypothesis,” (ii) the
“modified dopamine hypothesis of schizophrenia,” and (iii) the
“dopamine hypothesis: version III.”
The dopamine receptor hypothesis goes back to studies report-
ing antipsychotics affecting the affinity of dopamine receptors
(31–33). Further evidence for the hypothesis was presented with
increased synaptic monoamine levels during the induction of
psychotic symptoms (34). The focus of this hypothesis rests on
the excess of dopamine receptors. Thus, the clinical treatment is
aimed at blocking the dopamine D2 subtype of the dopamine
receptors (35).
The modified dopamine hypothesis of schizophrenia has been
formulated to integrate new findings (36). Preclinical and clini-
cal studies (i.e., post-mortem, metabolite, and dopamine receptor
neuroimaging studies) have advanced the understanding of rela-
tionships between affinity and occupancy of D2 and D1 subtypes of
the dopamine receptors and regional specificity (37). Furthermore,
it was assumed that findings of altered regional dopaminergic
receptor function from preclinical and indirect clinical studies
could be linked to clinical symptomatology in schizophrenia (36).
The hypothesis suggests that “hypofrontality,” as measured with
reduced regional cerebral blood flow (rCBF) in the PFC may indi-
cate low dopamine levels in the PFC (36). Findings from preclinical
3Exemplary studies on verbal fluency findings are presented.
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lesion studies proposed that prefrontal “hypodopaminergia” lead
to striatal “hyperdopaminergia” (38, 39). In addition, it is hypoth-
esized that prefrontal “hypodopaminergia” could cause negative
symptoms, whereas striatal “hyperdopaminergia” could lead to
positive symptoms (36).
The dopamine hypothesis: version III synthesizes published
findings on dopamine and its potential role in schizophrenia from
the main fields into one unifying hypothesis. The hypothesis aims
to provide a framework for findings from developments in clini-
cal research into genetic (risk) factors, environmental risk factors,
neurochemical and neuroimaging studies, and preclinical studies,
which may be related to increased presynaptic striatal dopamin-
ergic function in schizophrenia (23). The hypothesis is comprised
of four components: (i) The interaction of “hits” such as fronto-
temporal dysfunction, genes, stress, and drugs may lead to striatal
dopamine dysregulation (i.e., increased presynaptic dopamine
synthesis capacity) and therefore to psychosis. (ii) It is hypoth-
esized that the primary dopaminergic dysfunction is located at
the presynaptic dopaminergic level instead of the D2 receptor
level. (iii) The hypothesis assumes that the dopamine dysregu-
lation combined with cultural and societal factors could lead to
future clinical diagnosis of “psychosis” rather than schizophrenia.
(iv) It is proposed that the dopamine dysfunction could change the
perception and judgment of stimuli (possibly through aberrant
salience), which could result in cognitive deficits (40, 41).
Recent meta-analyses, which examined markers of striatal
dopamine alterations in schizophrenia, reported evidence of dif-
ferent types of elevated dopamine dysfunction. Supporting evi-
dence for the dopamine hypothesis has been shown by increased
striatal presynaptic dopaminergic function in medication-free
or medication-naïve patients with schizophrenia contrasted to
healthy controls (42) and increased striatal dopamine synthesis
capacity (43). Contradictory findings have however been reported
by Fusar-Poli and Meyer-Lindenberg (44), who found no dif-
ference in striatal dopamine active transporter density between
patients with schizophrenia and healthy controls.
In summary, while both the dopamine receptor hypothesis
and the modified dopamine hypothesis of schizophrenia have
their origins in the neurobiological investigation of the mode
of action of antipsychotics, the dopamine hypothesis: version III
aims at integrating advances in research of schizophrenia into
one unifying dopamine hypothesis. The scope of understanding
of dopaminergic dysregulation has become more defined, rang-
ing from the whole brain perspective, through the perspective of
regional specificity between (DL)PFC and striatum, to the current
perspective of elevated presynaptic striatal dopaminergic function.
The development of the dopamine hypothesis over the three ver-
sions has helped shape the understanding of schizophrenia as a
brain disorder.
GLUTAMATE HYPOTHESIS OF SCHIZOPHRENIA
The origin of the glutamate hypothesis of schizophrenia was based
on the discovery of psychotomimetic effects of ketamine and phen-
cyclidine, which elicited psychotic symptoms in healthy people.
Symptoms such as delusions and hallucinations experienced by
healthy individuals were compared to positive symptoms seen in
FES (45, 46). The glutamate hypothesis postulates a mechanistic
process of altered interacting glutamatergic and/or dopaminergic
neurotransmitter circuitries implicated in the pathophysiology of
clinical and cognitive symptoms in schizophrenia (47–50). In this
review, we consider three models of the glutamate hypothesis with
relevance to the investigation of altered working memory function
in people with schizophrenia: (i) the “N -Methyl-d-aspartate acid
(NMDA) receptor hypofunction model” of schizophrenia, (ii) the
“acute ketamine model,” and (iii) the “dysconnection hypothesis”
of schizophrenia.
The NMDA receptor hypofunction model of schizophrenia
posits that the subtype of the glutamate receptor is implicated in
multiple pathological brain mechanisms of schizophrenia rang-
ing across cellular, chemical, and neuronal levels (51–54). It has
been proposed that NMDA receptor hypofunction could under-
lie the pathophysiology of negative and cognitive symptoms in
schizophrenia (29, 51, 55, 56). Clinical trials with agents modulat-
ing NMDA receptor in addition to treatment with first-generation
antipsychotics (FGA; such as chlorpromazine, haloperidol, per-
phenazine) and second-generation antipsychotics (SGA; such as
clozapine and olanzapine) presented supporting evidence for
amelioration of negative and cognitive symptoms (51, 57, 58).
Evidence for the involvement of NMDA receptor hypofunction
through interactions among different neurotransmitters such asγ-
aminobutyric acid (GABAergic) interneurons (51) and dopamine
(59, 60) has also been reported.
Evidence for the glutamate hypothesis in humans is based on
clinical studies with ketamine in healthy subjects. Results suggest
that glutamatergic alterations could explain the pathophysiolog-
ical mechanisms resulting in positive symptoms predominantly
experienced by FES and those with first episode psychosis (FEP)
(45, 61). While findings from ketamine injection studies have aided
the understanding of glutamatergic signaling in the development
of delusions and hallucinations, evidence for altered glutamatergic
transmission in negative and cognitive symptoms is scarce. FMRI
findings from ketamine studies in healthy subjects propose that
altered glutamatergic signaling could be implicated in working
memory (12, 45, 62). These findings are in keeping with evi-
dence from glutamatergic animal models, which report aberrant
working memory function after the inhibition of glutamatergic
receptors (63–66).
The dysconnection hypothesis of schizophrenia posits that
altered NMDA receptor-mediated synaptic plasticity may be the
underlying pathophysiological mechanism in individuals with
schizophrenia (20, 21, 67). The authors propose that altered synap-
tic plasticity may explain both clinical symptoms and cognitive
deficits in people with schizophrenia neurobiologically by altered
NMDA receptor neuromodulation. Therefore, the dysconnection
hypothesis synthesizes neurobiological findings (i.e., dopamine
as one of the main neuromodulators leading to aberrant NMDA
receptor function) with clinical and cognitive neuroscientific find-
ings (i.e., cognitive impairment) in individuals with schizophrenia.
One of the main objectives of the dysconnection hypothesis is to
offer a new approach and therefore new interpretation of neuro-
physiological and neuroimaging data. This may be used to assist
in the understanding of altered cognitive function in people with
schizophrenia. For functional neuroimaging data, the biophysi-
cal modeling approach of dynamic causal modeling [DCM; Ref.
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(18)] has been proposed to infer biophysical processes (namely,
NMDA receptor-dependent synaptic plasticity) underlying the
blood-oxygen-level-dependent (BOLD) responses. In addition,
the authors provide arguments that the development of positive
symptoms such as delusions can be explained by a “failure of self-
monitoring mechanism” or “corollary discharge” (20). Abnormal
EC findings from EEG and fMRI studies across a range of cognitive
tasks in subjects with schizophrenia in contrast to healthy con-
trols have been reported (68–70). These lead to a new insight into
altered connectivity above those provided by FC studies, which
are formulated under different theoretical frameworks, specifi-
cally DCM findings enable the inference of biophysical processes
underlying neural responses (18, 19, 71).
In summary, the three hypotheses, the NMDA receptor hypo-
function model, the acute ketamine model, and the dysconnection
hypothesis, have motivated researchers to investigate biophysical
circuit processes implicated in glutamatergic and dopaminer-
gic interaction in negative symptoms and cognitive function in
schizophrenia. These circuit mechanisms are thought to under-
lie altered working memory function in schizophrenia. Research
on the NMDA receptor hypofunction model has its roots in the
pharmacological examination of antipsychotics, the development
of new agents, and its effects on clinical and cognitive symptoms
in preclinical and clinical research in schizophrenia. The focus of
researchers examining the acute ketamine model and the dyscon-
nection hypothesis lies on elucidating proposed neurobiological
processes of blockade of NMDA receptor underlying altered cog-
nitive brain function in schizophrenia. The study designs of both
versions differ in the investigation of (i) the pharmacological effect
of ketamine on altered cognitive brain function and clinical symp-
tomatology in healthy controls (the acute ketamine model) and (ii)
altered synaptic plasticity during altered cognitive brain function
in subjects with schizophrenia. Despite the different approaches,
researchers of both versions of the glutamate hypothesis share
the common aim of increasing our insight into schizophrenia by
the translation of neurobiological knowledge from basic research
to clinical research in schizophrenia. Furthermore, researchers
share the common methodological approach of large-scale net-
work analysis of fMRI data. Taken together, development over the
three versions of the glutamate hypothesis of schizophrenia have
presented promising evidence for shaping the understanding of
schizophrenia as a cognitive brain network disorder.
SCHIZOPHRENIA AS A COGNITIVE BRAIN DISORDER
Clinical and cognitive neuroscience studies have applied in vivo
neuroimaging techniques of fMRI, PET, and single-photon emis-
sion computed tomography (SPECT) to assess neurobiological
processes that underlie working memory function in people with
schizophrenia. Techniques such as PET and SPECT use injec-
tions of positron-emitting radionuclide as tracer (for PET) or
gamma-emitting radionuclide as tracer (for SPECT) in the liv-
ing brain. Although these nuclear medical imaging techniques are
non-invasive they require the administration of tracers. FMRI pro-
vides non-invasive in vivo imaging, which measures brain function
by means of the BOLD response (72).
In the last two decades, the fields of clinical and cognitive
neurosciences merged to provide a multidisciplinary approach to
research into schizophrenia. This approach has created the notion
of schizophrenia as a cognitive brain disorder (15, 73, 74).
EXAMPLES OF fMRI AND PET STUDIES INVESTIGATING ALTERED
WORKING MEMORY FUNCTION IN SUBJECTS WITH SCHIZOPHRENIA
Working memory tasks were initially investigated with fMRI in
healthy subjects (75–78). These initial findings led to the use of
fMRI as a tool for examining neurobiological markers that could
be related to working memory performance. The examination
of working memory function was extended to individuals with
schizophrenia.
Reported findings of brain function during working mem-
ory (among several domains and components of working mem-
ory tasks) in healthy controls have led to the understanding
that dopamine modulates working memory in healthy controls
(79–81). This evidence of dopaminergic involvement in working
memory was extended by the findings of altered dopaminergic
modulation in schizophrenia (74, 82). Subsequently, converging
findings were reported that regions such as DLPFC, anterior cin-
gulate cortex (ACC), and parietal cortex (PC) are activated in
working memory in both healthy controls and in subjects with
schizophrenia (83–86). However, in those with schizophrenia,
these regions exhibit increased or reduced functional activations
and FC between prefrontal and parietal regions as well as between
prefrontal and temporal regions in contrast to healthy controls.
Alterations in FC occur at all stages of the illness (87, 88): (i) in
HR subjects (89); (ii) in FES and FEP (90), and (iii) in subjects
with EST (91).
Systematic reviews and meta-analyses of working memory
fMRI studies in people with schizophrenia do not report con-
sistent findings (92–95). Some studies report increased activation
of the DLPFC, commonly referred to as “hyperfrontality,” how-
ever, others report decreased activation or “hypofrontality.” This
picture of differing functional activation in terms of the direc-
tion, extent, and/or pattern of BOLD responses was attributed to
the variation of domains and components of working memory
tasks (92–95). Also it was considered that methodological factors
in the applied analyses would contribute to these variations in
functional activation (93, 95, 96). In addition, differences in med-
ication could contribute to variation in the reported functional
activation between studies.
Here, we review exemplary fMRI studies using the numeric or
verbal “N-back” task in subjects with EST and healthy controls,
which reported functional activation and FC findings (Table 1).
The reviewed studies present group differences between subjects
with schizophrenia and healthy controls. In functional activa-
tion studies, evidence was reported for increased activation in
DLPFC, PFC, ventral PFC, medial frontal gyrus, and AC during
high working memory load in subjects with EST (89, 97–101).
However, reduced activation in prefrontal regions, such as ven-
tral PFC, DLPFC, AC, and parietal regions was found during high
working memory load in subjects with EST (97, 98, 102). One
study in FES found a reduction of activation in inferior frontal
gyrus (IFG), superior frontal gyrus, and AC during high working
memory load (103). We note three factors, which contributed to
difficulties in comparing the findings across the reviewed stud-
ies: (i) missing information of phase of schizophrenia (100), (ii)
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heterogeneous groups of subjects with EST (97, 101, 103), and
(iii) limited information on antipsychotic treatment (89, 97–101,
103). Fundamentally, none of the functional activation findings
was interpreted in context of the dopamine or glutamate hypothe-
sis. The lack of a clear understanding in terms of neural activation
and pathophysiological mechanism suggests there is a need for
studies examining wider prefrontal circuitry underlying working
memory deficits in schizophrenia (93, 95).
Functional connectivity studies applied voxel-based seed
approaches to the BOLD response (89, 100, 103), with the excep-
tion of one study, which applied an ROI-to-ROI approach (101).
Despite equivalent methodological approaches, the FC findings
are not entirely comparable due to the use of different seed loca-
tions. Findings of reduced connectivity involving subregions of
the PFC were found in FES and EST. Reduced FC findings in
subjects with schizophrenia and EST were reported in the major-
ity of studies: (i) Reduced prefrontal–parietal4 FC in subjects
with schizophrenia (100); (ii) Reduced prefrontal–hippocampal,
prefrontal–striatal, and within-PFC FC in EST (89); and (iii)
Reduced parieto-prefrontal FC and between putamen and ventro-
lateral PFC in EST (101). Further evidence for reduced FC between
medial frontal gyrus and putamen was found in FES (103). In con-
trast to most studies that report reduced FC in the early and late
phases of the illness, increased FC between the ventral PFC and
posterior PC was shown in subjects with schizophrenia (100). The
findings of both reduced and increased FC between subregions
of the PFC and the posterior PC may be related to variations in
behavioral response to task load for subjects with schizophrenia
(100). Similar difficulties in comparing the FC findings among
the studies are present as in the comparison of the functional acti-
vation studies due to unclear and missing information regarding
the illness phase, diagnosis, and medication treatment. Similarly,
no reference is made to the dopamine or glutamate hypothesis in
interpreting the FC findings.
In summary, findings presented by FC studies during the “N-
back” task have paved the way for the understanding of large-
scale functional networks in working memory. Furthermore, the
insight of brain alterations in subjects with schizophrenia has
advanced with FC from individually activated regions to con-
nectivity between brain regions. The perspective of circuit-based
neurobiology and cognitive brain function opens the doors for
translational research from preclinical and clinical research in
schizophrenia. However, FC is limited as the connection assess-
ments are based upon regional correlations and this approach does
not allow inferences of directions or causality between connected
regions (18).
Positron emission tomography and SPECT imaging in schiz-
ophrenia research are used to investigate indirect markers of
dopamine measures such as D2/3 receptors, presynaptic dopamin-
ergic function, dopamine synthesis capacity, dopamine release,
and dopamine transporters. Three [H215O] PET studies consis-
tently reported reduced rCBF in DLPFC and PC in verbal/numeric
“2-back” in subjects with EST in contrast to healthy controls (104–
106). Reduced prefrontal–hippocampal FC findings in subjects
4Reduced FC between the dorsal PFC and posterior PC.
with schizophrenia in contrast to healthy controls (105, 106)
confirmed the hypothesis of reduced functional connections in
working memory. Correlational PET studies provided support for
dopaminergic alterations and measures of the “2-back” task in
subjects with schizophrenia (2, 16).
In summary, fMRI and PET studies in the field of clinical
and cognitive neurosciences have been used to investigate brain
function during working memory in people with schizophrenia
(Figure 1). Both fMRI and PET findings have advanced the under-
standing of altered working memory performance and brain func-
tion in subjects with schizophrenia. This has led to better insight
into the interaction between altered working memory function
and experimental/clinical factors (such as cognitive domains of
working memory function, performance level, phases of illness,
clinical symptomatology, and effects of antipsychotic medication)
in individuals with schizophrenia.
EXAMPLES OF fMRI STUDIES INVESTIGATING ALTERED SPATIAL
WORKING MEMORY FUNCTION – GLUTAMATE HYPOTHESIS OF
SCHIZOPHRENIA
The role of the DLPFC in working memory deficits has been
associated with glutamatergic alterations and more specifically in
dopamine–glutamate interactions (10, 50, 51). Furthermore, it has
been reported that ketamine, a NMDA receptor antagonist, can
induce psychosis-like symptoms in healthy subjects (45). Here, we
briefly summarize the main functional activation and FC findings
of fMRI studies on the spatial “N-back” task in the context of the
glutamate hypothesis of schizophrenia (Table 2).
Anticevic et al. (12) presented ketamine-induced reduced func-
tional activation in task-activated regions (such as the DLPFC and
the precuneus) and task-deactivated regions of the default-mode
network (DMN). In addition, the combination of a spiking local-
circuit model of performance during the spatial “N-back” task and
the functional activation findings revealed that the modulation of
FIGURE 1 | Understanding of schizophrenia as a cognitive brain
disorder – verbal/numeric “N-back” task. afMRI; bPET, positron emission
tomography.
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ketamine alters the association between the task-activated and the
task-deactivated networks. Finally, it was shown that ketamine
modulates FC between the fronto-parietal and DMN networks.
In a recent study, Driesen et al. (62) provided further support for
ketamine-induced reduced prefrontal FC during the spatial “N-
back” task. Two FC approaches with the same seed regions were
employed, seed-based FC and global-based connectivity (GBC),
which revealed both decreased FC within the DLPFC. The seed-
based analysis resulted in reduced FC between DLPFC and mid-
dle frontal gyrus [MFG, IFG, and insula (among other regions)
under ketamine in contrast to saline]. The GBC analysis showed
decreased FC of the DLPFC under ketamine.
In summary, these studies on altered spatial working memory
function inform on the glutamate hypothesis, through the acute
ketamine model (Figure 2). In this, they have advanced the under-
standing of NMDA receptor-modulated brain function in healthy
subjects.
FROM COMPUTATIONAL NEUROPSYCHIATRY TOWARD
SCHIZOPHRENIA AS A COGNITIVE BRAIN NETWORK
DISORDER
Clinical and cognitive neurosciences have advanced the under-
standing of altered working memory function in subjects with
schizophrenia. FMRI studies in working memory among other
neuroimaging and electrophysiological techniques, have reported
on functional activation and FC findings in subjects with schizo-
phrenia. Both findings of functional activation and FC revealed
methodological, cognitive, and clinical factors related to our
understanding of altered working memory function in patients
with schizophrenia. In particular, FC findings mark the begin-
ning of the notion of “disconnection” and “dysconnection” (20,
21, 67, 107) in working with people with schizophrenia. FC is
defined as the statistical association or dependency among two or
more anatomically distinct time-series (107). FC findings cannot
be interpreted in terms of causal effects between connected regions
and thus, does not allow for a mechanistic inference of the BOLD
responses.
The modeling of functional large-scale networks5 during work-
ing memory function in schizophrenia could provide mechanistic
explanations for altered brain function in individuals with schiz-
ophrenia. The advantage of modeling functional large-scale net-
works in terms of EC over FC is that inferences can be drawn
on mechanistic processes, which are not directly observable in the
BOLD response.
COMPUTATIONAL NEUROSCIENCE AND COMPUTATIONAL
NEUROPSYCHIATRY
Marr proposes a theoretical framework for computational research
on the brain on three levels (1976). At the first level, researchers
should aim to gain knowledge of the high-level computations of
the brain such as working memory (“computational level”). At the
next level, the testing of the brain’s methods and algorithms for the
high-level working memory function is led by hypotheses derived
from the acquired knowledge and testing how appropriate an algo-
rithm such as Bayesian inference is for modeling the working
5As one subfield within computational psychiatry.
FIGURE 2 | Understanding of schizophrenia as a cognitive brain
disorder – spatial “N-back” task.
memory brain function (“algorithmic level”). Finally, when an
algorithm is found, which is valid and more likely than alterna-
tive algorithms to predict known brain function/behavior, then
the investigation of the biological implementation can be pursued
(“physical level”).
Computational neuropsychiatry is an emerging field within
computational neuroscience. Computational neuropsychiatry
aims to provide an explanatory bridge between altered cogni-
tive function and neurobiological mechanisms associated with
the development of mental illness (108, 109, Huys, unreferred
preprint). Computational neuropsychiatry in humans has been
defined by outlining a set of components, which include bio-
physical modeling and computational modeling (109). Differ-
ent types of computational models at different neural levels are
used dependent on the study hypothesis (108, Huys, unreferred
preprint).
COMPUTATIONAL NEUROPSYCHIATRY AND MODELING OF
FUNCTIONAL LARGE-SCALE NETWORKS IN SUBJECTS WITH
SCHIZOPHRENIA
Connectionist and neural network models in working mem-
ory/cognitive control in subjects with schizophrenia have added
to our understanding of both the brain function and the neuro-
biological mechanism underlying working memory (74, 76). The
strength of these models is based on the translational link between
human brain function (i.e., functional activation) and preclini-
cal neurobiological evidence (namely, dopaminergic modulation)
during working memory.
Following on from the work of Cohen and Braver, evidence for
the understanding of schizophrenia as a cognitive network disor-
der has been presented by both preclinical studies (8, 10, 110–113)
and human FC studies in working memory (89, 100, 101, 103).
Recent studies examining biophysical mechanisms underlying
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altered functional large-scale networks aim to bridge the gap
between the human functional network used in working mem-
ory and the preclinical neurobiological processes. Examples of
such computational neuropsychiatric studies, including EC dur-
ing working memory in subjects with schizophrenia, are reviewed.
In this, we focus on DCM studies investigating the numeric/verbal
“N-back” task in subjects with schizophrenia and healthy controls.
This is considered in the context of the dopamine and glutamate
hypotheses of schizophrenia. Both neurobiological hypotheses
have contributed to the formulation of research objectives in
computational neuropsychiatry (114) and the development of
computational modeling techniques of fMRI data in subjects with
schizophrenia (20).
Dynamic causal modeling for fMRI – examples of modeling
functional large-scale networks
Dynamic causal modeling for fMRI has been introduced as a
method to provide insight into the notion of “functional inte-
gration” during cognitive performance. “Functional integration”
has been advanced from the historic notion of “functional special-
ization” (115), which is defined by context-dependent interactions
among different brain regions (18, 116–118).
Dynamic causal modeling has been described as a biophysical
modeling of neuronal dynamic processes (18, 19)6, which can be
used as a method for the computation of synaptic plasticity from
fMRI task-based studies (20, 21). Together biophysical modeling
and Bayesian inference analysis form the framework for DCM (71,
117, 118). Thus, DCM is a modeling approach, which combines
defined network models (i.e., hypotheses) with Bayesian inver-
sion methods (19, 117). Specifically, DCM assesses inter-regional
EC through assessment of experimentally induced changes (18)
and therefore allows for mechanistic inferences from neuronal
function.
Bilinear DCM infers dynamics at the neuronal level by translat-
ing modeled neuronal responses into predicted BOLD measure-
ments (18). Non-linear DCM for fMRI (71, 119) is an advanced
approach for increasing the biological plausibility of DCMs by the
means of modeling “gain modulation” (i.e., non-linear modula-
tion of neuronal connections) (19, 117, 118). In non-linear DCM,
the modulation of connection strengths by experimental inputs is
supplemented by direct modulation of neural activity in one or
more network regions (18, 119). The computations for gating in
neural networks use the multiplicative computation of non-linear
modulation (120, 121). Accordingly, non-linear DCM can be used
for inferring that the strength of a connection is modulated by
activity of other neuronal populations (119, 122).
Findings of altered effective connectivity during working mem-
ory in subjects with schizophrenia. The first DCM studies in
healthy controls described large-scale networks in working mem-
ory and a similar task [continuous performance test; (123–125)].
A recent study in healthy controls built the linkage between EC
results and underlying dopaminergic modulation of large-scale
6We consider DCM as the generative model approach as introduced in the seminal
article by Friston et al. (18).
networks comprising of the DLPFC and PC during verbal memory
performance (126).
To date four DCM studies have examined the verbal/numeric
“N-back” task in subjects with schizophrenia using bilinear DCM
(127–130) (Table 3). These provide novel insights into reduced
task-dependent EC and increased task-independent EC measures
through modeling large-scale networks in schizophrenia.
In the first study, increased fronto-temporal intrinsic connec-
tivity was found to be associated with increased functional acti-
vation of the superior temporal gyrus (STG) during the numeric
“N-back” task in the subjects at the prodromal and at the acutely
psychotic stage of schizophrenia in contrast to the healthy controls.
This suggests a potential marker for vulnerability to the disorder
(127). Furthermore, progressively decreased intrinsic connectiv-
ity between the STG and the MFG in subjects at-risk mental state
(ARMS) and FES subjects in contrast to the healthy controls was
reported. This finding suggested that functional activation may
resemble increased task-independent EC between the PFC and
the STG. However, the results of the study are not comparable to
other DCM studies because (i) only one model was examined and
(ii) the biological plausibility of the EC measures is not clearly
accessible. No reference to the dopamine or glutamate hypotheses
was made.
The second study investigated the working memory-dependent
modulatory effect for the prefrontal–parietal connectivity in sub-
jects with EST and healthy subjects during the numeric “N-back”
task (128). The large-scale networks included the right DLPFC, the
PC, and the visual cortex with bidirectional connection between all
regions. The main finding was decreased task-dependent EC from
the DLPFC to the PC in the subjects with EST. Thus, this finding
could resemble evidence for the glutamate hypothesis of schizo-
phrenia, specifically the NMDA receptor hypofunction model and
the dysconnection hypothesis.
The third study examined possible vulnerability markers for
psychosis from the verbal “N-back” task in ARMS subjects, FES
subjects, and healthy subjects (129). This study examined reduced
task-dependent EC measures as well as relationships between con-
nectivity parameters and antipsychotic medication received by
subjects. In this study, EC in interhemispheric large-scale net-
works between the bilateral superior parietal lobes (SPL) and the
bilateral MFG was assessed. This study reported novel findings
of progressively decreased working memory and induced mod-
ulation of connectivity between the MFG and the SPL (from
healthy subjects to ARMS). Additionally, further decreased EC
of modulatory effects were observed in non-medicated subjects
with FEP contrasted to healthy controls. Evidence for ameliora-
tion of reduced EC between the MFG and the SPL in subjects with
FES, who received SGA medication, could reflect alterations of
dopaminergic regulation of NMDA receptor-dependent synaptic
plasticity of fronto-parietal connections. However, this interpre-
tation is limited by the lack of a control group of FES who are
treated with different types of antipsychotic medication. These
findings across different subpopulations of schizophrenia together
with the effect of antipsychotic medication may reflect support for
the NMDA receptor hypofunction model and the dysconnection
hypothesis.
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In the fourth study, Zhang et al. (130) explored EC measures
in terms of possible neurobiological markers in groups of subjects
with schizophrenia with high or low suicide risk and contrasted
these with healthy controls during the verbal “N-back” task. The
large-scale networks were defined by unidirectional and bidirec-
tional connections between the two regions of the medial PFC and
PC as well as working memory effects on these regions. This pilot
study presented novel findings in subjects with schizophrenia at
suicidal risk in terms of increased intrinsic connectivity from the
PC to the MFG in both groups with FES (in comparison to healthy
controls). This finding was interpreted as a possible association to
schizophrenia, in which increased intrinsic connectivity from the
MFG to the PC in the subjects with high risk of suicide could reflect
vulnerability of suicide. However, the results are not directly com-
parable to the other DCM studies because of the study population,
which focused on the issue of suicide. The findings were also not
interpreted in context of the dopamine or glutamate hypotheses.
We highlight main experimental and methodological limita-
tions in the four DCM studies, which impede the comparability
of findings (please see Table 3 for details). The main experimen-
tal limitation focuses on the discrepancies between the different
patient subpopulations. Two studies analyzed working memory
fMRI data of subjects with ARMS and FES in comparison to
healthy controls (127, 129), whereas one study modeled scans from
subjects with EST (128). Zhang et al. (130) reported findings of
a unique patient population of FES with high and low suicidal
risk. In terms of methodological issues, one limitation lies in dif-
ferent definitions of model spaces for the large-scale networks,
despite equivalence in the experimental tasks. Another limitation
is that the reviewed DCM studies employed deterministic DCM
for the comparison of the models. Deterministic models can pre-
dict processes perfectly if all inputs are known (131). However, at
this early stage of employing biophysical modeling approaches to
human brain function, we do not have a full understanding of the
brain responses to working memory. Future studies may employ
stochastic DCM as an extension (117, 118, 132). A further limita-
tion is that different DCM versions were applied across the four
studies, which impede the comparability of the findings. The pri-
ors are differently defined in the used DCM versions, which give
rise to a variation in model evidence between the studies (117).
Thus, it is possible that discrepancies in EC findings could be due
to the prior definition and may not be solely due to differences in
performance, brain function, or clinical aspects of subjects with
schizophrenia. Lastly, a general limitation of DCM for fMRI is
that maximally 10 regions within a large-scale network can be
modeled. This simplification results in difficulties of biophysical
modeling of tasks, which are likely to encompass more than ten
regions. Furthermore, not only the definition of different regions
and different numbers of regions but also different modulatory
inputs result in further extensions to the model space. Such model
spaces are difficult to validate and analyze.
The four DCM studies presented evidence for increased task-
dependent EC and increased task-independent EC findings during
verbal/numeric working memory in subjects with schizophrenia.
We discuss these EC findings in context of (i) the dopamine and
glutamate hypothesis and (ii) FC findings during verbal/numeric
working memory in subjects with schizophrenia.
The four studies modeled large-scale networks during the “N-
back” task in subjects with schizophrenia. However, only two out
of these four studies consider their DCM results in the light of bio-
physical processes (128, 129). The findings of reduced EC (namely,
the effect of task-modulation) of the prefrontal–parietal connec-
tion in subjects with schizophrenia in contrast to healthy controls
were interpreted biophysically and linked to the NMDA recep-
tor hypofunction model and the dysconnection hypothesis (128,
129). Both studies reported reduced EC findings of the prefrontal–
parietal connection during working memory, however, these find-
ings need to be considered carefully due to different experimental
designs (i.e., patient subpopulations, antipsychotic medication
treatment of FGA and SGA) and methodological implementation
(i.e., model space, DCM settings, and inference techniques).
Three of the DCM studies reported altered EC findings of
the prefrontal–parietal and parieto-prefrontal connections dur-
ing the “N-back” task in subjects with schizophrenia in contrast to
healthy controls. Deserno et al. (128) and Schmidt et al. (129) pre-
sented reduced EC (effect of task-modulation) of the prefrontal–
parietal connection in subjects with schizophrenia in contrast to
healthy controls, whereas Zhang et al. (130) found increased EC
(intrinsic connectivity) of the parietal–prefrontal connection. The
reduced task-dependent EC findings are in keeping with reduced
FC findings of these connections, although increased FC between
a different prefrontal subregion and the PC was reported (100).
The study by Crossley et al. (127) reported increased EC (intrin-
sic connectivity) of the prefrontal–temporal connection in subjects
at HR and FES (in contrast to healthy controls). Reduced FC
of the prefrontal–temporal connection during the “N-back” task
in subjects with schizophrenia has been previously reported in
PET studies (105, 106). However, the regions within the PFC and
temporal region differ between the studies.
Findings of altered effective connectivity during verbal fluency
in subjects with schizophrenia. Here, we discuss bilinear and
non-linear DCM studies, which have assessed large-scale networks
during verbal fluency [namely, the Hayling sentence completion
task (HSCT)] in subjects with schizophrenia and healthy controls
(Table 4). One bilinear DCM study in healthy controls investi-
gated the task-dependent modulation of response initiation and
response suppression in EC between left hemispheric temporal
and prefrontal regions (133). The main finding was a difference in
connection strength of the modulatory effect in response initiation
and response suppression.
Two clinical bilinear DCM studies have investigated EC mea-
sures during the HSCT in HR subjects and healthy controls: (i)
Subjects at high clinical risk of schizophrenia [ARMS; Ref. (134)]
and (ii) subjects at high familial risk of schizophrenia (135). Allen
et al. (134) investigated increased fronto-temporal EC (intrinsic
connectivity) as a potential measure of vulnerability of develop-
ing schizophrenia. Two main findings were reported: firstly, no
significant effect of task-dependent modulation on the fronto-
temporal connection between ARMS subjects and healthy controls
was revealed. Secondly, ARMS subjects displayed increased intrin-
sic connectivity between the ACC and the MTG in comparison
to healthy controls. Furthermore, the Bayesian model selection
(BMS) approach revealed that the same network was equally likely
www.frontiersin.org March 2014 | Volume 5 | Article 30 | 11
Dauvermann et al. Schizophrenia as a cognitive brain network disorder
Ta
b
le
4
|S
ch
iz
o
p
h
re
n
ia
as
a
co
g
n
it
iv
e
b
ra
in
n
et
w
o
rk
d
is
o
rd
er
II
–
su
m
m
ar
y
o
f
m
ai
n
fi
n
d
in
g
s
in
ve
rb
al
fl
u
en
cy
–
n
eu
ro
im
ag
in
g
an
d
b
io
p
hy
si
ca
lm
o
d
el
in
g
.
S
tu
d
y
S
u
b
je
ct
s
–
p
h
as
e
o
f
sc
h
iz
o
p
h
re
n
ia
;
H
C
–
H
R
,F
E
S
/F
E
P,
E
S
T
M
ed
ic
at
io
n
E
xp
er
im
en
ta
l
p
ar
ad
ig
m
N
et
w
o
rk
s
–
m
o
d
el
sp
ac
e;
n
u
m
b
er
o
f
m
o
d
el
s;
re
g
io
n
s
D
C
M
se
tt
in
g
s
–
D
C
M
ve
rs
io
n
;
sp
h
er
e
si
ze
;
in
fe
re
n
ce
te
ch
n
iq
u
e(
s)
M
ai
n
fi
n
d
in
g
(s
)
(1
34
)
15
H
C
;1
5
H
R
a
2
H
R
ris
pe
rid
on
e
an
d
qu
et
ia
pi
ne
c
H
C
ST
14
Le
ft
he
m
is
ph
er
ic
m
od
el
s;
M
FG
,A
C
C
,M
TG
D
C
M
in
S
P
M
5;
12
m
m
sp
he
re
s;
ra
nd
om
-e
ffe
ct
s
B
M
S
4
↑I
C
be
tw
ee
n
A
C
C
an
d
M
TG
;
sa
m
e
w
in
ni
ng
m
od
el
in
bo
th
gr
ou
ps
(1
35
)
19
H
C
;2
6
H
R
b
–
20
H
R
+,
4
H
R
ill
N
ot
m
ed
ic
at
ed
H
C
ST
8
Le
ft
he
m
is
ph
er
ic
m
od
el
s;
3
m
od
el
fa
m
ili
es
;I
P
S,
IF
G
,A
C
C
,
M
TG
,M
D
th
al
am
us
D
C
M
8
in
S
P
M
8;
8
m
m
sp
he
re
s
(IP
S,
D
LP
FC
,M
TG
);
6
m
m
sp
he
re
s
(A
C
C
,M
D
th
al
am
us
);
R
an
do
m
-e
ffe
ct
s
B
M
S
d,
e
;B
M
A
Pr
og
re
ss
iv
el
y
↓c
on
ne
ct
io
n
st
re
ng
th
w
ith
no
n-
lin
ea
r
m
od
ul
at
io
n
of
th
e
th
al
am
o-
co
rt
ic
al
co
nn
ec
tio
n
in
H
R
+
an
d
H
R
ill
in
co
nt
ra
st
to
H
C
↑In
cr
ea
se
d
in
su
bj
ec
ts
w
ith
sc
hi
zo
ph
re
ni
a
in
co
nt
ra
st
to
H
C
.
↓D
ec
re
as
ed
in
su
bj
ec
ts
w
ith
sc
hi
zo
ph
re
ni
a
in
co
nt
ra
st
to
H
C
.
A
C
C
,a
nt
er
io
r
ci
ng
ul
at
e
co
rt
ex
;A
R
M
S,
su
bj
ec
ts
w
ith
at
-r
is
k
m
en
ta
ls
ta
te
;B
M
A
,B
ay
es
ia
n
m
od
el
av
er
ag
in
g;
B
M
S,
B
ay
es
ia
n
m
od
el
se
le
ct
io
n;
E
C
,e
ffe
ct
iv
e
co
nn
ec
tiv
ity
;F
E
P,
su
bj
ec
ts
w
ith
fir
st
ep
is
od
e
ps
yc
ho
si
s;
FE
S,
su
bj
ec
ts
w
ith
fir
st
ep
is
od
e
sc
hi
zo
ph
re
ni
a;
H
C
,h
ea
lth
y
co
nt
ro
ls
;H
R
−,
su
bj
ec
ts
at
hi
gh
fa
m
ili
al
ris
k
of
sc
hi
zo
ph
re
ni
a
w
ith
ou
t
tr
an
si
en
t
ps
yc
ho
tic
sy
m
pt
om
s;
H
R
+,
su
bj
ec
ts
at
hi
gh
fa
m
ili
al
ris
k
of
sc
hi
zo
ph
re
ni
a
w
ith
tr
an
si
en
tp
sy
ch
ot
ic
sy
m
pt
om
s;
H
R
ill
,s
ub
je
ct
s
at
fa
m
ili
al
ris
k
of
sc
hi
zo
ph
re
ni
a
w
ho
su
bs
eq
ue
nt
to
th
e
sc
an
ni
ng
de
ve
lo
pe
d
sc
hi
zo
ph
re
ni
a;
H
S
C
T,
H
ay
lin
g
se
nt
en
ce
co
m
pl
et
io
n
ta
sk
;I
C
,i
nt
rin
si
c
co
nn
ec
tiv
ity
;I
FG
,
in
fe
rio
r
fr
on
ta
lg
yr
us
;I
P
S,
in
tr
ap
ar
ie
ta
ls
ul
cu
s;
M
D
m
ed
io
do
rs
al
;M
FG
,m
id
dl
e
fr
on
ta
lg
yr
us
;M
TG
,m
id
dl
e
te
m
po
ra
lg
yr
us
;
a
S
ub
je
ct
s
at
hi
gh
cl
in
ic
al
ris
k
of
sc
hi
zo
ph
re
ni
a.
b
S
ub
je
ct
s
at
hi
gh
fa
m
ili
al
ris
k
of
sc
hi
zo
ph
re
ni
a.
c A
t
th
e
tim
e
of
sc
an
ni
ng
.
d
B
M
S
at
th
e
gr
ou
p-
le
ve
l.
e
B
M
S
at
th
e
m
od
el
fa
m
ily
le
ve
l.
Frontiers in Psychiatry | Schizophrenia March 2014 | Volume 5 | Article 30 | 12
Dauvermann et al. Schizophrenia as a cognitive brain network disorder
to explain the given HSCT fMRI data in both the ARMS subjects
and the healthy controls. No reference to the glutamate hypothesis
was made.
Dauvermann et al. (135) modeled EC measures in a similar
version of the HSCT that was used by Allen et al. (134). This
study was conducted in subjects at high familial risk of schizo-
phrenia and healthy subjects. The results reported by Allen et al.
(134) of a similar large-scale network in both HR subjects and
healthy controls was replicated7. This finding was also confirmed
by Dauvermann et al. (135), when the group of HR subjects was
subdivided into high risk subjects without transient psychotic
symptoms (referred to as HR−), high risk subjects with transient
psychotic symptoms (referred to as HR+) and high risk subjects
who subsequent to scanning developed schizophrenia [referred to
as HRill; please see Ref. (136, 137)]. Comparability between these
two studies is limited due to differences in the model space. The
model space in Dauvermann et al. (135) includes the IPS and the
mediodorsal thalamus, which are not incorporated in the model
space by Allen et al. (134). In addition, endogenous connections
and task-dependent modulations were accordingly changed [Ref.
(135); Table 4]. There was no reference to the glutamate hypothesis
of schizophrenia.
Limitations of bilinear DCM have been addressed through the
development of non-linear DCM for fMRI (119). This method
was applied in the genetic high risk study reported by Dau-
vermann et al. (135). The progress from the bilinear DCM to
the non-linear DCM as reported by Dauvermann is based on
the biophysical modeling of connection strength with non-linear
modulation during the HSCT response. The authors show that
relative to healthy controls there is reduced connection strength
with non-linear modulation of the thalamo-cortical connection
during the HSCT in HR+ subjects and a further reduction in
this connection strength in HRill subjects (135). The authors sug-
gest that reduced gain control may underlie the reduced strength
in the thalamo-cortical connection. Furthermore, the findings of
reduced connection strength with non-linear modulation of the
thalamo-cortical connection could reflect altered glutamatergic
neurotransmission, which may underlie a disruption of synaptic
plasticity in this thalamo-cortical connection [Ref. (135); Table 4].
Thus, the findings were interpreted in context of the NMDA
receptor hypofunction model and the dysconnection hypothesis.
Summary of studies modeling functional large-scale
networks – dynamic causal modeling for fMRI
Evidence from brain function in working memory in subjects with
schizophrenia at the level of functional large-scale networks (i.e.,
clinical and cognitive neurosciences) and neurobiological mech-
anisms in working memory in animal models of schizophrenia
(preclinical neurobiological research) in combination with com-
putational neuroscientific approaches has informed and enabled
research in computational neuropsychiatry.
Exemplary DCM studies in subjects with schizophrenia have
reported both increased and reduced EC findings during cogni-
tion in subjects with schizophrenia in contrast to healthy controls.
7It is noted, however, that the large-scale networks differed slightly from the previous
study.
These studies applied DCM as a biophysical modeling approach
to functional large-scale networks, which enabled the interpreta-
tion of EC findings on the basis of the glutamate hypothesis of
schizophrenia, namely the NMDA receptor hypofunction model
and the dysconnection hypothesis (128, 129, 135). We empha-
size that the findings support not only the glutamate hypoth-
esis but also the dopamine hypothesis. Dopamine is a neuro-
modulator that may crucially affect glutamate-induced synaptic
plasticity. Synaptic plasticity may be involved in a regulation
of dopamine synthesis and release via other neurotransmitter
systems. Specifically for non-linear effects, it has been shown
that dopamine acts as a neuromodulator mediating postsynaptic
gain (74, 138).
In a recent study, it has been reported that the combination
of the DCM analysis of numerical “N-back” task in EST (128)
and generative embedding resulted in the dissection of three
subgroups of EST based on the mechanistically inferred DCM
findings (139). This exemplary study showed that DCM can be
applied as a generative model of large-scale networks in indi-
viduals with schizophrenia. In summary, DCM is a promising
approach for modeling synaptic plasticity; nevertheless in its cur-
rent form it cannot reflect the full complexity in the processing
required for the implementation of tasks such as working memory
(Figure 3).
UNDERSTANDING OF SCHIZOPHRENIA IN DEVELOPMENT
Our understanding of schizophrenia is in continuous development
and with more preclinical and clinical findings being published this
understanding will advance further. A critical aspect of this under-
standing is the facilitation of multidisciplinary approach between
preclinical and clinical research in schizophrenia.
The original understanding of schizophrenia as a brain disorder
stems from observational clinical work, which led onto preclinical
FIGURE 3 | Understanding of schizophrenia as a cognitive brain
network disorder – verbal/numeric “N-back” task.
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investigation. Over time, the knowledge of alterations of cellular,
chemical, and molecular mechanisms has increased: (i) findings of
dopaminergic and glutamatergic modulation of working memory
(and clinical features) in animal models of schizophrenia con-
tributed to form the understanding of schizophrenia as a cognitive
brain disorder; (ii) findings of neurotransmitter circuit systems,
mainly dopaminergic and glutamatergic systems, were found to
modulate working memory in animal models of schizophrenia
in combination with computational studies (140), which plays a
role in shaping the understanding of schizophrenia as a cognitive
network disorder.
Understanding of schizophrenia has not only been shaped by
preclinical research but also by clinical research in subjects with
schizophrenia, which has been and continues to be illuminated by
preclinical neurobiological and computational work. The field of
clinical and cognitive neurosciences has contributed to forming
our understanding of schizophrenia as a cognitive brain dis-
order. Importantly, the multidisciplinary field of computational
neuropsychiatry (preclinical neurobiology, clinical and cognitive
neurosciences, and computational psychiatry) has allowed for
progress in our understanding of schizophrenia as a cognitive
brain network disorder.
SCHIZOPHRENIA AS COGNITIVE BRAIN NETWORK DISORDER
The use of computational neuropsychiatric research in developing
our understanding of schizophrenia as a cognitive brain network
disorder is at an early stage. Here, we focused on FC and EC studies
(DCM studies) during the verbal/numeric “N-back” task in sub-
jects with schizophrenia and healthy controls. We discuss these
FC and EC findings in context of two key research questions.
Consideration of these questions was seen as a means to inform
future schizophrenia research in the fields of clinical and cognitive
neurosciences and/or computational neuropsychiatry:
To what extent do these sets of findings support the dopamine
hypothesis and/or the glutamate hypothesis in subjects with
schizophrenia?
Studies reported both increased and reduced FC during the “N-
back” task in subjects with schizophrenia in contrast to healthy
controls. These findings have introduced the notion of human
large-scale networks underlying brain function during working
memory. The FC correlational analyses do not allow for the
inference of directions or weights of in functional connections.
Thus, from FC findings it is not practical to draw inferences on
neurobiological causal processing.
Studies, which applied DCM as a biophysical modeling
approach to functional large-scale networks, showed that reduced
EC findings could be interpreted in context of the NMDA receptor
hypofunction model and the dysconnection hypothesis.
In summary, FC findings cannot be interpreted in context
of the dopamine or glutamate hypothesis. For EC findings, the
computational neuropsychiatric approach of modeling large-
scale networks requires biophysically plausible networks, which
are hypothesis-driven from neurobiological and cognitive neu-
roscience in subjects with schizophrenia. EC findings have been
interpreted in the context of the glutamate hypothesis and the
dopamine hypothesis.
Do the findings from computational neuropsychiatry lead to a gain
in understanding of schizophrenia in comparison to the findings
from clinical and cognitive neurosciences?
Functional connectivity findings from cognitive and clinical neu-
roscience have contributed to the understanding of schizophrenia
as a cognitive brain disorder. The analysis of altered working
memory at the level of large-scale networks has advanced our
knowledge of cognitive function in humans. However, it is not
wholly understood what altered FC during cognition neurobio-
logically means in schizophrenia. EC findings from computational
neuropsychiatry, here specifically modeling functional large-scale
networks with DCM, have shown indications of linkage between
clinical network-based working memory (large-scale networks)
and preclinical neurotransmitter modulation of cognitive func-
tion. Altered synaptic plasticity during working memory can be
interpreted with dopaminergic and glutamatergic mechanisms.
We emphasize that the interpretation of altered neurotransmitter
circuits should be considered carefully because the DCM method is
likely to underestimate the processing complexity in neurobiolog-
ical circuits. Nonetheless, a strength of DCM lies in interpretation
of altered synaptic plasticity based on the inference of mechanistic
information.
The consideration of schizophrenia as a cognitive brain net-
work disorder from computational neuropsychiatry offers a holis-
tic view of schizophrenia. Computational neuropsychiatry seeks
to bridge the gap between neurobiology and cognitive and clinical
neurosciences in subjects with schizophrenia. It is hoped that this
research will enhance our understanding of schizophrenia, clinical
treatment, and improve outcome in people with schizophrenia.
FUTURE OUTLOOK AND OPEN QUESTIONS
The reviewed findings in biophysical modeling of functional large-
scale networks are promising. In order to reach the objective of
predicting and improving clinical treatment in subjects with schiz-
ophrenia, longitudinal study designs, and the combination of sub-
fields within computational neuropsychiatry should be pursued.
We consider computational neuropsychiatric research areas
for the combination of biophysical modeling of functional
large-scale networks and other computational (neuro)psychiatric
approaches, which are of clinical relevance for subjects with
schizophrenia, for example:
• Neurotransmitter systems
• Behavior
• Clinical symptoms
• Effects of antipsychotic medication
• Clinical outcome.
We suggest specific study designs, which may increase our
understanding for developing clinical treatment for subjects with
schizophrenia:
(i) Combination of biophysical modeling of functional large-
scale networks with computation, for example:
(a) Brain function and brain circuit model (12);
(b) Brain function and behavior (141);
(c) Brain function and effect of antipsychotic medication:
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(ii) Combination of biophysical modeling of functional large-
scale networks with multimodal neuroimaging study designs,
for example:
(a) FMRI and EEG/magnetoencephalography study designs;
(b) FMRI and transcranial magnetic stimulation study
designs (142);
(c) FMRI and MRS study designs;
(d) FMRI and PET study designs;
(iii) Combination of biophysical modeling of functional large-
scale networks and computational modeling for the investi-
gation of clinical (sub)groups, for example:
(a) Associative learning (143, 144);
(b) Machine learning approach (139, 145);
(c) Reinforcement learning (109).
Findings of modeling functional large-scale networks con-
tribute to shaping the understanding of schizophrenia as a cog-
nitive brain network disorder. The combination of computa-
tional neuropsychiatric areas may bring researchers closer to the
common long-term objectives of developing a diagnostic tool
for schizophrenia along with the development of more effective
treatments.
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APPENDIX
DYNAMIC CAUSAL MODELING
Dynamic causal modeling is general framework for model-
based assessment of competing theories about neuronal cir-
cuits (18, 146). In particular, DCM is a generic Bayesian system
identification technique, which allows for inference on “hid-
den” neurophysiological mechanisms that generated observed
measures, such as blood-oxygen-level-dependent signal in func-
tional magnetic resonance imaging (fMRI) or evoked responses
measured with electroencephalography (EEG). The principle
idea thereby is to formulate a simplified model of neuronal
population responses (z) and combine this with a modality-
specific forward model (λ) such that one can predict the mea-
surement (y) that would arise from any particular neuronal
circuit (18).
In DCM for fMRI, the dynamics of the neural states under-
lying regional BOLD response are modeled by a bilinear dif-
ferential equation that describes how the neural states (x)
change over time (t ) as a function of endogenous inter-regional
connections (matrix A), modulatory effects on these connec-
tions (matrix B), and direct (driving) inputs (matrix C) (Eq.
A1) (18, 122). The endogenous connections represent coupling
strengths in the absence of input uj to the system, whereas
the modulatory effects represent task-specific alterations in this
connectivity.
f (x , u) = dx
xt
=
(
A +
m∑
i=1
uB(j)
)
x + Cu (A1)
The bilinear state equation has subsequently been extended by
a non-linear term, where the modulation of connection strengths
by experimental inputs is supplemented by direct modulation
with neural activity in one or more regions (119). In other
words, non-linear DCMs allow addressing how the connection
between two neuronal units is gated by activity in other units.
This is of particular interest as gating processes represent a key
mechanism for many neurobiological processes and thus increas-
ing the biological realism of non-linear compared to bilinear
DCMs. To this end, compared with the bilinear state equation,
the new term in the non-linear equations are the D matrices
(Eq. A2), which encode how the n regions gate connections in
the system.
f (x , u) = dx
dt
=
A + m∑
i=1
uB(j) +
n∑
j=1
xjD
(j)
 x + Cu (A2)
BAYESIAN MODEL SELECTION AND BAYESIAN MODEL AVERAGING
Bayesian model selection is an essential procedure of DCM studies
as it can be used to test competing hypotheses (different DCMs)
about the neural mechanisms generating the data. BMS rests on
comparing the evidence of a predefined set of models (the model
space). The model evidence is the probability of observing the
empirical data, given a model, and represents a principled mea-
sure of model quality, derived from probability theory (147, 148).
Concretely, it represents the mean predicted data under random
sampling from the model’s priors or, alternatively, a principled
measure of the balance between model fit and model complexity. A
random-effects BMS approach has been suggested for group stud-
ies, which is capable of quantifying the degree of heterogeneity in a
population while being extremely robust to potential outliers (20,
67). The probability that one model is more likely than any other
model, given the group data, can be expressed by the exceedance
probability (ϕk) of each model:
∃k ∈ {1 . . . k},∀j ∈ {1 . . . k|j 6= k} :
ϕk = p(rk > rj |y ; a)
After inference on the most likely network architecture under-
lying a specific neural process, one can compare the parameter
estimates of the most likely model obtained from BMS (winning
model) for between-group inferences. However, statistical com-
parison of model parameter estimates across groups is only valid
if those estimates stem from the same model. Given that different
models may be found to be optimal across groups, Bayesian model
averaging (BMA) has been recommended as standard approach
for clinical DCM studies (146). BMA averages posterior para-
meter estimates over models, weighted by the posterior model
probabilities (148). Thus, models with a low posterior probabil-
ity contribute little to the estimation of the marginal posterior.
In brief, BMS and BMA are central components of DCM studies
to infer on neural mechanisms at the neural system level and on
specific model parameters across groups, respectively (146).
In non-linear DCM analysis, the connection strengths between
selected nodes are assessed for activity-dependent modulation of
the reciprocal neuronal projections by the introduction of gating
mechanisms. Non-linear DCM is applied to the models identified
as winning models from the application of bilinear state equation.
The bilinear model and the non-linear models differ only in the
introduction of gating mechanisms such as a parametric response
in the tested functional task. Such gating mechanisms are applied
to nodal connections, which are expected to explain the varia-
tion in subject response to the functional task. The appropriate
placement of the gating input is assessed through the application
of model space partitioning and family inference. The exceedance
probabilities of the models are compared and the non-linear mod-
els,which provide higher exceedance probabilities than the bilinear
models are identified as winning models.
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